These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33576348)

  • 1. [Side effects of antibiotic: diarrhea and Clostridium difficile infection.].
    Capurso L; Koch M
    Recenti Prog Med; 2021 Jan; 112(1):4-26. PubMed ID: 33576348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shifts in the Gut Metabolome and
    Fletcher JR; Erwin S; Lanzas C; Theriot CM
    mSphere; 2018; 3(2):. PubMed ID: 29600278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.
    Theriot CM; Young VB
    Gut Microbes; 2014; 5(1):86-95. PubMed ID: 24335555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea.
    Abad CLR; Safdar N
    Gastroenterol Clin North Am; 2021 Jun; 50(2):323-340. PubMed ID: 34024444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
    Lesniak NA; Schubert AM; Sinani H; Schloss PD
    mSphere; 2021 May; 6(3):. PubMed ID: 33952668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut associated metabolites and their roles in
    Aguirre AM; Sorg JA
    Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions Between the Gastrointestinal Microbiome and Clostridium difficile.
    Theriot CM; Young VB
    Annu Rev Microbiol; 2015; 69():445-61. PubMed ID: 26488281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Colonization Resistance Against Clostridioides difficile.
    Pike CM; Theriot CM
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S194-S200. PubMed ID: 33326565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection.
    Theriot CM; Koenigsknecht MJ; Carlson PE; Hatton GE; Nelson AM; Li B; Huffnagle GB; Z Li J; Young VB
    Nat Commun; 2014; 5():3114. PubMed ID: 24445449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.
    Knecht H; Neulinger SC; Heinsen FA; Knecht C; Schilhabel A; Schmitz RA; Zimmermann A; dos Santos VM; Ferrer M; Rosenstiel PC; Schreiber S; Friedrichs AK; Ott SJ
    PLoS One; 2014; 9(2):e89417. PubMed ID: 24586762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
    Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
    Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile salt metabolism is not the only factor contributing to
    Jukes CA; Ijaz UZ; Buckley A; Spencer J; Irvine J; Candlish D; Li JV; Marchesi JR; Douce G
    Gut Microbes; 2020 May; 11(3):481-496. PubMed ID: 31793403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbe-microbe interactions during Clostridioides difficile infection.
    Abbas A; Zackular JP
    Curr Opin Microbiol; 2020 Feb; 53():19-25. PubMed ID: 32088581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of a sequencing-based clinical intestinal screening test in patients at high-risk for Clostridium difficile and other pathogens: a case report.
    Hitschfeld M; Tovar E; Gupta S; Bik EM; Palmer C; Hoaglin MC; Almonacid DE; Richman J; Apte ZS
    J Med Case Rep; 2019 Jan; 13(1):9. PubMed ID: 30642394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapies and preventative strategies for primary and recurrent Clostridium difficile infections.
    Dieterle MG; Rao K; Young VB
    Ann N Y Acad Sci; 2019 Jan; 1435(1):110-138. PubMed ID: 30238983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of the gut microbiota during the Clostridioides difficile infection in tree shrews mimics those in humans.
    Gu W; Li W; Wang W; Kuang D; Zhang W; Lu C; Li N; Tong P; Han Y; Sun X; Lu J; Wu Y; Dai J
    BMC Microbiol; 2020 Aug; 20(1):260. PubMed ID: 32819295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
    Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
    BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance.
    Tomkovich S; Taylor A; King J; Colovas J; Bishop L; McBride K; Royzenblat S; Lesniak NA; Bergin IL; Schloss PD
    mSphere; 2021 Oct; 6(5):e0062921. PubMed ID: 34585964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin-3-Gallate Improves Intestinal Gut Microbiota Homeostasis and Ameliorates
    Wu Z; Shen J; Xu Q; Xiang Q; Chen Y; Lv L; Zheng B; Wang Q; Wang S; Li L
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145133
    [No Abstract]   [Full Text] [Related]  

  • 20. Clostridium butyricum enhances colonization resistance against Clostridioides difficile by metabolic and immune modulation.
    Hagihara M; Ariyoshi T; Kuroki Y; Eguchi S; Higashi S; Mori T; Nonogaki T; Iwasaki K; Yamashita M; Asai N; Koizumi Y; Oka K; Takahashi M; Yamagishi Y; Mikamo H
    Sci Rep; 2021 Jul; 11(1):15007. PubMed ID: 34294848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.